
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeted Anti-Mitochondrial Therapy: The Future of Oncology
Farzad Taghizadeh‐Hesary, Hassan Akbari, Moslem Bahadori, et al.
Genes (2022) Vol. 13, Iss. 10, pp. 1728-1728
Open Access | Times Cited: 36
Farzad Taghizadeh‐Hesary, Hassan Akbari, Moslem Bahadori, et al.
Genes (2022) Vol. 13, Iss. 10, pp. 1728-1728
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
Overcoming Chemotherapy Resistance in Metastatic Cancer: A Comprehensive Review
Maryam Eslami, Omid Memarsadeghi, Ali Davarpanah, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 183-183
Open Access | Times Cited: 29
Maryam Eslami, Omid Memarsadeghi, Ali Davarpanah, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 183-183
Open Access | Times Cited: 29
Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity
Farzad Taghizadeh‐Hesary, Mohammad Houshyari, Mohammad Farhadi
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 9, pp. 6719-6741
Closed Access | Times Cited: 29
Farzad Taghizadeh‐Hesary, Mohammad Houshyari, Mohammad Farhadi
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 9, pp. 6719-6741
Closed Access | Times Cited: 29
Mitochondrial Metabolism: A New Dimension of Personalized Oncology
Babak Behnam, Farzad Taghizadeh‐Hesary
Cancers (2023) Vol. 15, Iss. 16, pp. 4058-4058
Open Access | Times Cited: 25
Babak Behnam, Farzad Taghizadeh‐Hesary
Cancers (2023) Vol. 15, Iss. 16, pp. 4058-4058
Open Access | Times Cited: 25
The genetic landscape and possible therapeutics of neurofibromatosis type 2
Mohammad Amin Ghalavand, Alimohamad Asghari, Mohammad Farhadi, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 21
Mohammad Amin Ghalavand, Alimohamad Asghari, Mohammad Farhadi, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 21
COVID-19 induced liver injury from a new perspective: Mitochondria
Hassan Akbari, Farzad Taghizadeh‐Hesary
Mitochondrion (2023) Vol. 70, pp. 103-110
Open Access | Times Cited: 17
Hassan Akbari, Farzad Taghizadeh‐Hesary
Mitochondrion (2023) Vol. 70, pp. 103-110
Open Access | Times Cited: 17
Nanodelivery systems: An efficient and target‐specific approach for drug‐resistant cancers
Sumel Ashique, Ashish Garg, Afzal Hussain, et al.
Cancer Medicine (2023) Vol. 12, Iss. 18, pp. 18797-18825
Open Access | Times Cited: 14
Sumel Ashique, Ashish Garg, Afzal Hussain, et al.
Cancer Medicine (2023) Vol. 12, Iss. 18, pp. 18797-18825
Open Access | Times Cited: 14
Phenylsulfonimide PPARα Antagonists Enhance Nrf2 Activation and Promote Oxidative Stress-Induced Apoptosis/Pyroptosis in MCF7 Breast Cancer Cells
M. Gallorini, Valentina Di Valerio, Isabella Bruno, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1316-1316
Open Access | Times Cited: 11
M. Gallorini, Valentina Di Valerio, Isabella Bruno, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1316-1316
Open Access | Times Cited: 11
Unveiling the impact of CD133 on cell cycle regulation in radio- and chemo-resistance of cancer stem cells
Luyao Wu, Takanori Katsube, Xiaofei Li, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Luyao Wu, Takanori Katsube, Xiaofei Li, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Mitochondria in cancer: a comprehensive review, bibliometric analysis, and future perspectives
Abeer El Wakil, Patrick Devos, Heba Abdelmegeed, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Abeer El Wakil, Patrick Devos, Heba Abdelmegeed, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Igniting Hope for Tumor Immunotherapy: Promoting the “Hot and Cold” Tumor Transition
Wei Chen, Yichao Ma, Fei Wang, et al.
Clinical Medicine Insights Oncology (2022) Vol. 16
Open Access | Times Cited: 17
Wei Chen, Yichao Ma, Fei Wang, et al.
Clinical Medicine Insights Oncology (2022) Vol. 16
Open Access | Times Cited: 17
The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy
Zakia Akter, Narges Salamat, Md. Yousuf Ali, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 10
Zakia Akter, Narges Salamat, Md. Yousuf Ali, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 10
Sumac-rose water mouthwash versus benzydamine to prevent radiation-induced oral mucositis in head and neck cancers: a phase II randomized trial
Ahmad Ameri, Ghazaleh Heydarirad, Rasoul Choopani, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 7427-7439
Closed Access | Times Cited: 9
Ahmad Ameri, Ghazaleh Heydarirad, Rasoul Choopani, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 7427-7439
Closed Access | Times Cited: 9
Predictive value of prognostic nutritional index (PNI) in recurrent or unresectable hepatocellular carcinoma received anti-PD1 therapy
Xindan Kang, Jing Wang, Kang Xue, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Xindan Kang, Jing Wang, Kang Xue, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Non-Small Cell Lung Cancer (NSCLC) in Young Adults, Age < 50, Is Associated with Late Stage at Presentation and a Very Poor Prognosis in Patients That Do Not Have a Targeted Therapy Option: A Real-World Study
D.J. Hughes, Matthaios Kapiris, Andreja Podvez Nevajda, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6056-6056
Open Access | Times Cited: 11
D.J. Hughes, Matthaios Kapiris, Andreja Podvez Nevajda, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6056-6056
Open Access | Times Cited: 11
The Metastatic Spread of Breast Cancer Accelerates during Sleep: How the Study Design can Affect the Results
Mohammad Houshyari, Farzad Taghizadeh‐Hesary
Asian Pacific Journal of Cancer Prevention (2023) Vol. 24, Iss. 2, pp. 353-355
Open Access | Times Cited: 6
Mohammad Houshyari, Farzad Taghizadeh‐Hesary
Asian Pacific Journal of Cancer Prevention (2023) Vol. 24, Iss. 2, pp. 353-355
Open Access | Times Cited: 6
Anti-mitochondrial Therapy: A New Dimension of Personalized Oncology
Babak Behnam, Farzad Taghizadeh‐Hesary
(2023)
Open Access | Times Cited: 5
Babak Behnam, Farzad Taghizadeh‐Hesary
(2023)
Open Access | Times Cited: 5
CSF-1R promotes vasculogenic mimicry via epithelial-mesenchymal transition in nasopharyngeal carcinoma cells
Huaqing Mo, Yanru Lv, Shan Gao, et al.
ONCOLOGIE (2023) Vol. 25, Iss. 3, pp. 317-325
Open Access | Times Cited: 5
Huaqing Mo, Yanru Lv, Shan Gao, et al.
ONCOLOGIE (2023) Vol. 25, Iss. 3, pp. 317-325
Open Access | Times Cited: 5
Ciliated, Mitochondria-Rich Postmitotic Cells are Immune-privileged, and Mimic Immunosuppressive Microenvironment of Tumor-Initiating Stem Cells: From Molecular Anatomy to Molecular Pathway
Babak Behnam, Hassan Fazilaty, M Ghadyani, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 10
Open Access | Times Cited: 5
Babak Behnam, Hassan Fazilaty, M Ghadyani, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 10
Open Access | Times Cited: 5
Combined transcriptomics and in-silico approach uncovers the role of prognostic biomarkers in hepatocellular carcinoma
Rubi Solanki, Prithvi Singh, Md Amjad Beg, et al.
Human Gene (2023) Vol. 35, pp. 201154-201154
Closed Access | Times Cited: 4
Rubi Solanki, Prithvi Singh, Md Amjad Beg, et al.
Human Gene (2023) Vol. 35, pp. 201154-201154
Closed Access | Times Cited: 4
Tumor Microenvironment Heterogeneity, Potential Therapeutic Avenues, and Emerging Therapies
Xintong Peng, Jingfan Zheng, Tianzi Liu, et al.
Current Cancer Drug Targets (2023) Vol. 24, Iss. 3, pp. 288-307
Closed Access | Times Cited: 4
Xintong Peng, Jingfan Zheng, Tianzi Liu, et al.
Current Cancer Drug Targets (2023) Vol. 24, Iss. 3, pp. 288-307
Closed Access | Times Cited: 4
Mitochondrial–Stem Cell Connection: Providing Additional Explanations for Understanding Cancer
Pierrick Martinez, Ilyes Baghli, Géraud Gourjon, et al.
Metabolites (2024) Vol. 14, Iss. 4, pp. 229-229
Open Access | Times Cited: 1
Pierrick Martinez, Ilyes Baghli, Géraud Gourjon, et al.
Metabolites (2024) Vol. 14, Iss. 4, pp. 229-229
Open Access | Times Cited: 1
Exploring the interplay between iron metabolism imbalance and esophageal cancer
Lu Qi, Zhongwen Li
ONCOLOGIE (2024) Vol. 26, Iss. 4, pp. 509-523
Closed Access | Times Cited: 1
Lu Qi, Zhongwen Li
ONCOLOGIE (2024) Vol. 26, Iss. 4, pp. 509-523
Closed Access | Times Cited: 1
Unveiling Cellular Secrets: Illuminating Carbon Dot Lighthouses for Improved Mitochondrial Exploration
Sathyaprakash Kumarasamy, Vinay Sharma
Chemistry of Materials (2024)
Closed Access | Times Cited: 1
Sathyaprakash Kumarasamy, Vinay Sharma
Chemistry of Materials (2024)
Closed Access | Times Cited: 1
The Interplay of Lung Cancer, COVID-19, and Vaccines
Dragan Trivanović, Željka Peršurić, Andrea Agaj, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15067-15067
Open Access | Times Cited: 6
Dragan Trivanović, Željka Peršurić, Andrea Agaj, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15067-15067
Open Access | Times Cited: 6
Enhanced Glycolysis Confers Resistance Against Photon but Not Carbon Ion Irradiation in Human Glioma Cell Lines
Mohit Vashishta, Vivek Kumar, Chandan Guha, et al.
Cancer Management and Research (2023) Vol. Volume 15, pp. 1-16
Open Access | Times Cited: 3
Mohit Vashishta, Vivek Kumar, Chandan Guha, et al.
Cancer Management and Research (2023) Vol. Volume 15, pp. 1-16
Open Access | Times Cited: 3